Viewing Study NCT00766116


Ignite Creation Date: 2025-12-26 @ 11:46 AM
Ignite Modification Date: 2025-12-26 @ 11:46 AM
Study NCT ID: NCT00766116
Status: COMPLETED
Last Update Posted: 2019-02-18
First Post: 2008-10-02
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Combination 5-azacitidine and Gemtuzumab Ozogamicin Therapy for Treatment of Relapsed Acute Myeloid Leukemia (AML)
Sponsor: University of California, San Diego
Organization: